Soligenix, Inc. (SNGX)
0.3681
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
0.3681
0.00 (0.00%)
After-Hours: 20:00
Soligenix Total Assets (Quarterly) : 10.50M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.50M |
| March 31, 2026 | 6.923M |
| December 31, 2025 | 9.236M |
| September 30, 2025 | 11.29M |
| June 30, 2025 | 5.761M |
| March 31, 2025 | 7.746M |
| December 31, 2024 | 8.966M |
| September 30, 2024 | 10.48M |
| June 30, 2024 | 9.865M |
| March 31, 2024 | 8.058M |
| December 31, 2023 | 9.797M |
| September 30, 2023 | 11.30M |
| June 30, 2023 | 13.83M |
| March 31, 2023 | 11.10M |
| December 31, 2022 | 14.28M |
| September 30, 2022 | 17.95M |
| June 30, 2022 | 21.31M |
| March 31, 2022 | 23.67M |
| December 31, 2021 | 26.87M |
| September 30, 2021 | 29.72M |
| June 30, 2021 | 29.61M |
| March 31, 2021 | 31.55M |
| December 31, 2020 | 19.89M |
| September 30, 2020 | 13.25M |
| June 30, 2020 | 12.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.848M |
| December 31, 2019 | 7.775M |
| September 30, 2019 | 8.332M |
| June 30, 2019 | 9.193M |
| March 31, 2019 | 9.521M |
| December 31, 2018 | 10.49M |
| September 30, 2018 | 13.29M |
| June 30, 2018 | 6.152M |
| March 31, 2018 | 7.479M |
| December 31, 2017 | 9.550M |
| September 30, 2017 | 5.852M |
| June 30, 2017 | 6.774M |
| March 31, 2017 | 8.409M |
| December 31, 2016 | 10.27M |
| September 30, 2016 | 7.754M |
| June 30, 2016 | 5.416M |
| March 31, 2016 | 5.591M |
| December 31, 2015 | 7.387M |
| September 30, 2015 | 6.355M |
| June 30, 2015 | 5.366M |
| March 31, 2015 | 5.903M |
| December 31, 2014 | 6.954M |
| September 30, 2014 | 6.273M |
| June 30, 2014 | 6.146M |
| March 31, 2014 | 7.013M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.854M |
| Shareholders Equity (Quarterly) | 6.646M |
| Debt to Equity Ratio | 0.0455 |
| Current Ratio | 2.769 |
| Net Debt Paydown Yield | -0.52% |